U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H13NO2S
Molecular Weight 283.345
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TAZEPROFEN

SMILES

CC(C(O)=O)C1=CC2=C(C=C1)N=C(S2)C3=CC=CC=C3

InChI

InChIKey=DPRKTNKWAXPYNW-UHFFFAOYSA-N
InChI=1S/C16H13NO2S/c1-10(16(18)19)12-7-8-13-14(9-12)20-15(17-13)11-5-3-2-4-6-11/h2-10H,1H3,(H,18,19)

HIDE SMILES / InChI

Molecular Formula C16H13NO2S
Molecular Weight 283.345
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Tazifylline (also known as LN 2974) is a long-acting histamine H1-receptor antagonist that was studied in clinical trials for the treatment of allergic rhinitis and asthma. In addition, this compound was studied on the itching and scratching of patients with atopic eczema. However, the further development of tazifylline appears to have been discontinued by Roche.

Approval Year

PubMed

PubMed

TitleDatePubMed
Multiple-dose pharmacokinetics of the new H1-receptor antagonist tazifylline in healthy volunteers.
1989-01-01
Antiallergic effects of the new histamine H1-receptor antagonist tazifylline in healthy atopic and non-atopic subjects.
1988-02
The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema.
1986-11
Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
1986-04

Sample Use Guides

10 mg b.i.d. for 8 days
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:33:00 GMT 2025
Edited
by admin
on Mon Mar 31 18:33:00 GMT 2025
Record UNII
S05RV1R3LZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
tazeprofen [INN]
Preferred Name English
TAZEPROFEN
INN  
INN  
Official Name English
Classification Tree Code System Code
NCI_THESAURUS C257
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
Code System Code Type Description
EVMPD
SUB10846MIG
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
NCI_THESAURUS
C76815
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
EPA CompTox
DTXSID20868927
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
ChEMBL
CHEMBL2104770
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
INN
5436
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
PUBCHEM
3086214
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
FDA UNII
S05RV1R3LZ
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
SMS_ID
100000082412
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
CAS
76816-33-6
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
SUPERSEDED
CAS
85702-89-2
Created by admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY